News
-
-
-
PRESS RELEASE
Wellgistics Health to Distribute Tollo Health GLP-1 Companion Muscle Loss Medical Food to Pharmacies & Physicians
Wellgistics Health introduces clinically validated dietary management for sarcopenia & SARS-CoV-2 antiviral combo for Long COVID, expanding agreements with pharmacy network and physicians -
-
PRESS RELEASE
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) to file Earnings Report on Form 10-Q for quarter ended September 30, 2025. Investor webcast on November 17, 2025 at 8:30 a.m. Eastern to review financials and provide corporate updates -
PRESS RELEASE
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
RedChip Companies to feature Connect Biopharma and Bimergen Energy Corp. interviews on Bloomberg TV's Small Stocks, Big Money show. Connect Biopharma discusses rademikibart's potential in respiratory diseases. Bimergen Energy focuses on utility-scale battery projects for grid reliability -
-
-
PRESS RELEASE
NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2
NanoViricides, Inc. to present NV-387, a revolutionary broad-spectrum antiviral drug, at Pharma Partnering Summit 2025. NV-387 mimics virus features to combat viral infections effectively -